Temporal changes in standard and tissue doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer

American Journal of Cardiology

Volumn 112, Issue 7, 2013, Pages 1005-1012

  Lotrionte, Marzia ^a   Cavarretta, Elena ^b   Abbate, Antonio ^c   Mezzaroma, Eleonora ^c   De Marco, Eugenia ^a   Di Persio, Silvia ^a   Loperfido, Francesco ^a   Biondi Zoccai, Giuseppe ^b   Frati, Giacomo ^b,d   Palazzoni, Giovanni ^e  

^a Division of Heart Failure and Cardiac Rehabilitation   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d IRCCS NEUROMED   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ECHOCARDIOGRAPH; FEMALE; FOLLOW UP; HEART ATRIUM CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUOROURACIL; HEART DISEASES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TAXOIDS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84884418590     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.038     Document Type: Article

References (27)

1. K.A. Wouters, L.C. Kremer, T.L. Miller, E.H. Herman, and S.E. Lipshultz Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies Br J Haematol 131 2005 561 578
2. J.C. Santin, D. Deheinzelin, S.P. Junior, L.F. Lopes, and B. de Camargo Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy J Pediatr Hematol Oncol 29 2007 761 765
3. S.E. Lipshultz, J.A. Alvarez, and R.E. Scully Anthracycline associated cardiotoxicity in survivors of childhood cancer Heart 94 2008 525 533
4. L. Gianni, E.H. Herman, S.E. Lipshultz, G. Minotti, N. Sarvazyan, and D.B. Sawyer Anthracycline cardiotoxicity: from bench to bedside J Clin Oncol 26 2008 3777 3784
5. T. Simůnek, M. Stérba, O. Popelová, M. Adamcová, R. Hrdina, and V. Gersl Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron Pharmacol Rep 61 2009 154 171
6. Y. Yao, X. Xu, G. Zhang, Y. Zhang, W. Qian, and T. Rui Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway Basic Res Cardiol 107 2012 267
7. E. Piegari, A. De Angelis, D. Cappetta, R. Russo, G. Esposito, S. Costantino, G. Graiani, C. Frati, L. Prezioso, L. Berrino, K. Urbanek, F. Quaini, and F. Rossi Doxorubicin induces senescence and impairs function of human cardiac progenitor cells Basic Res Cardiol 108 2013 334
8. M. Galderisi, F. Marra, R. Esposito, V.S. Lomoriello, M. Pardo, and O. de Divitiis Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography Cardiovasc Ultrasound 5 2007 4
9. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, G. De Giacomi, M. Rubino, F. Veglia, C. Fiorentini, and C.M. Cipolla Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
10. M. Airoldi, D. Amadori, S. Barni, S. Cinieri, S. De Placido, A. Di Leo, A. Gennari, S. Iacobelli, M.T. Ionta, V. Lorusso, M. Lotrionte, P. Marchetti, R. Mattioli, G. Minotti, P. Pronzato, G. Rosti, C.A. Tondini, and A. Veronesi Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review Tumori 97 2011 690 692
11. M. Lotrionte, G. Palazzoni, R. Natali, G. Comerci, A. Abbate, S. Di Persio, and G.G. Biondi-Zoccai Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-tissue Doppler imaging evaluation) randomized pilot study Int J Cardiol 135 2009 72 77
12. Lotrionte M, Palazzoni G, Abbate A, De Marco E, Mezzaroma E, Di Persio S, Frati G, Loperfido F, Biondi-Zoccai G. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study. Int J Cardiol Epub 2012 Nov 19.
13. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart, Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, and European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
14. S. De Castro, E. Cavarretta, A. Milan, S. Caselli, E. Di Angelantonio, D. Vizza Carmine, D. Lucchetti, A. Patel, J. Kuvin, and N.G. Pandian Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo-derived right ventricular ejection fraction Echocardiography 25 2008 289 293
15. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, and M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533
16. S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, J.K. Oh, M.M. Redfield, and A.J. Tajik Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study Circulation 102 2000 1788 1794
17. B. Marchandise, E. Schroeder, A. Bosly, C. Doyen, P. Weynants, R. Kremer, and H. Pouleur Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics Am Heart J 118 1989 92 98
18. S. Tassan-Mangina, D. Codorean, M. Metivier, B. Costa, C. Himberlin, C. Jouannaud, A.M. Blaise, J. Elaerts, and P. Nazeyrollas Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study Eur J Echocardiogr 7 2006 141 146
19. M.F. Stoddard, J. Seeger, N.E. Liddell, T.J. Hadley, D.M. Sullivan, and J. Kupersmith Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans J Am Coll Cardiol 20 1992 62 69
20. L.J. Steinherz, P.G. Steinherz, C.T. Tan, G. Heller, and M.L. Murphy Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1991 1672 1677
21. J.M. Appel, B. Zerahn, S. Møller, H.M. Christensen, P. Søgaard, B. Ejlertsen, N. Fogh-Andersen, B.V. Jensen, and D.L. Nielsen Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer Acta Oncol 51 2012 1054 1061
22. R.Q. Migrino, D. Aggarwal, E. Konorev, T. Brahmbhatt, M. Bright, and B. Kalyanaraman Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography Ultrasound Med Biol 34 2008 208 214
23. K. Greaves, R. Puranik, J.J. O'Leary, and D.S. Celermajer Myocardial tissue velocities in the normal left and right ventricle: relationships and predictors Heart Lung Circ 13 2004 367 373
24. E. Cavarretta, G. Casella, B. Calì, C. Dammaro, G. Biondi-Zoccai, A. Iossa, F. Leonetti, G. Frati, and N. Basso Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy World J Surg 37 2013 565 572
25. S. Toldo, R.W. Goehe, M. Lotrionte, E. Mezzaroma, E.T. Sumner, G.G. Biondi-Zoccai, I.M. Seropian, B.W. Van Tassell, F. Loperfido, G. Palazzoni, N.F. Voelkel, A. Abbate, and D.A. Gewirtz Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse PLoS One 8 2013 e58421
26. D. Garcia-Dorado, M. Andres-Villarreal, M. Ruiz-Meana, J. Inserte, and I. Barba Myocardial edema: a translational view J Mol Cell Cardiol 52 2012 931 939
27. J. Zhu, J. Zhang, D. Xiang, Z. Zhang, L. Zhang, M. Wu, S. Zhu, R. Zhang, and W. Han Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity Eur J Pharmacol 643 2010 247 253